As of 2026-03-08, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (6.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -326.7%.
The range of the Relative Valuation is (5.34) - (7.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 20.4x | 17.8x |
| Forward P/E multiples | 13.9x - 20.3x | 16.1x |
| Fair Price | (5.34) - (7.40) | (6.17) |
| Upside | -296.3% - -372.0% | -326.7% |
| Date | P/E |
| 2026-03-06 | -7.48 |
| 2026-03-05 | -7.61 |
| 2026-03-04 | -8.00 |
| 2026-03-03 | -8.00 |
| 2026-03-02 | -8.99 |
| 2026-02-27 | -9.21 |
| 2026-02-26 | -9.24 |
| 2026-02-25 | -9.15 |
| 2026-02-24 | -9.07 |
| 2026-02-23 | -9.18 |
| 2026-02-20 | -9.57 |
| 2026-02-19 | -9.68 |
| 2026-02-18 | -9.81 |
| 2026-02-17 | -9.76 |
| 2026-02-13 | -9.43 |
| 2026-02-12 | -9.35 |
| 2026-02-11 | -9.51 |
| 2026-02-10 | -9.32 |
| 2026-02-09 | -9.13 |
| 2026-02-06 | -9.35 |
| 2026-02-05 | -8.74 |
| 2026-02-04 | -9.40 |
| 2026-02-03 | -9.65 |
| 2026-02-02 | -9.62 |
| 2026-01-30 | -9.32 |
| 2026-01-29 | -9.76 |
| 2026-01-28 | -9.51 |
| 2026-01-27 | -9.40 |
| 2026-01-26 | -9.18 |
| 2026-01-23 | -8.63 |
| 2026-01-22 | -8.71 |
| 2026-01-21 | -8.19 |
| 2026-01-20 | -7.94 |
| 2026-01-16 | -8.36 |
| 2026-01-15 | -8.60 |
| 2026-01-14 | -8.88 |
| 2026-01-13 | -9.07 |
| 2026-01-12 | -9.76 |
| 2026-01-09 | -10.67 |
| 2026-01-08 | -10.75 |
| 2026-01-07 | -10.56 |
| 2026-01-06 | -10.23 |
| 2026-01-05 | -10.47 |
| 2026-01-02 | -10.20 |
| 2025-12-31 | -10.17 |
| 2025-12-30 | -10.14 |
| 2025-12-29 | -10.69 |
| 2025-12-26 | -11.11 |
| 2025-12-24 | -10.86 |
| 2025-12-23 | -10.67 |